Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
Episodes 76-90 of 259
Optimizing Second-Line CAR T Decisions in R/R Large B-Cell Lymphoma
Project Oncology®Optimizing Second-Line CAR T Decisions in R/R Large B-Cell Lymphoma
Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Project Oncology®Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Optimizing PI3Kα Testing and Therapy in HR+/HER2- Advanced Breast Cancer Care
Project Oncology®Optimizing PI3Kα Testing and Therapy in HR+/HER2- Advanced Breast Cancer Care
Enhancing Efficacy and Safety in HR+/HER2- Breast Cancer with Novel PI3Kα Inhibitors
Project Oncology®Enhancing Efficacy and Safety in HR+/HER2- Breast Cancer with Novel PI3Kα Inhibitors
Targeting PI3Kα-Mutated HR+/HER2- Breast Cancer in the Second-Line Setting
Project Oncology®Targeting PI3Kα-Mutated HR+/HER2- Breast Cancer in the Second-Line Setting
Redefining First-Line Treatment in Endometrial Cancer: The Role of Immunotherapy
Project Oncology®Redefining First-Line Treatment in Endometrial Cancer: The Role of Immunotherapy
- advertisement
Advancing Endometrial Cancer Care: ADCs and Biomarker-Based Therapies
Project Oncology®Advancing Endometrial Cancer Care: ADCs and Biomarker-Based Therapies
Subcutaneous Pembrolizumab in mNSCLC: A Potential Shift in the Delivery Landscape
Project Oncology®Subcutaneous Pembrolizumab in mNSCLC: A Potential Shift in the Delivery Landscape
From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
Project Oncology®From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
Putting Patients First: Personalized Care in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerPutting Patients First: Personalized Care in Metastatic Breast Cancer
Disaster-Proofing Colorectal Cancer Screening: What We Learned from COVID-19
Clinician's RoundtableDisaster-Proofing Colorectal Cancer Screening: What We Learned from COVID-19
Debunking CAR T-Cell Myths: The Realities of Patient Selection, Safety, and Access
Project Oncology®Debunking CAR T-Cell Myths: The Realities of Patient Selection, Safety, and Access
- advertisement
Clinical Decision-Making in Metastatic Breast Cancer: Optimizing Sequencing Choices
On the Frontlines of Metastatic Breast CancerClinical Decision-Making in Metastatic Breast Cancer: Optimizing Sequencing Choices
DESTINY-Breast04 Findings: T-DXd and Quality of Life in HER2-Low Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerDESTINY-Breast04 Findings: T-DXd and Quality of Life in HER2-Low Metastatic Breast Cancer
Improving Metastatic Breast Cancer Care Through Integrated Palliative Support
On the Frontlines of Metastatic Breast CancerImproving Metastatic Breast Cancer Care Through Integrated Palliative Support
